sonidegib phosphate · Sun Pharm · NDA 205266
Odomzo
Earliest generic entry, as listed
30 Mar 2036
Blocked by patent: US 10266523.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10266523 | substance, product | 30 Mar 2036 |
| US 8063043 | substance, product | 15 Sep 2029 |
| US 8178563 | substance, use U-1722 | 24 Jul 2029 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 205266 · 001 · RLD | capsule, oral | EQ 200MG BASE | 30 Mar 2036 |